Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation

Sensitized patients received desensitization therapy with rituximab for kidney transplantation. However, the impact of rituximab dose on hepatitis B virus (HBV) reactivation is unknown. Patients who underwent living donor kidney transplantation between 2008 and 2016 were grouped according to rituxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Juhan, Park, Jun Yong, Kim, Deok Gie, Lee, Jee Youn, Kim, Beom Seok, Kim, Myoung Soo, Il Kim, Soon, Kim, Yu Seun, Huh, Kyu Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199240/
https://www.ncbi.nlm.nih.gov/pubmed/30353021
http://dx.doi.org/10.1038/s41598-018-34111-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199240/
https://www.ncbi.nlm.nih.gov/pubmed/30353021
http://dx.doi.org/10.1038/s41598-018-34111-5

Ejemplares similares